LINASUG-5
MRP: 3,000
Packaging: 10x10
Pack Type: tablet
Composition:
Linagliptin 5 mg
Indication:
used along with diet and exercise and sometimes with other medications to lower blood sugar levels in patients with type 2 diabetes
Description:
Linagliptin 5 mg is an oral antidiabetic medication used in the management of type 2 diabetes mellitus. It belongs to the class of DPP-4 (Dipeptidyl Peptidase-4) inhibitors, which work by increasing the levels of incretin hormones. These hormones help regulate blood glucose by enhancing insulin secretion and decreasing glucagon levels in a glucose-dependent manner.
Linagliptin stands out among DPP-4 inhibitors due to its non-renal route of excretion, making it suitable for patients with renal impairment without the need for dose adjustment. It is often used alone or in combination with other antidiabetic agents like metformin, sulfonylureas, or insulin to achieve optimal glycemic control.
Tags:
- Effectively lowers HbA1c and blood glucose levels
- Minimal risk of hypoglycemia when used alone
- Safe in patients with kidney dysfunction
- Can be used in combination with other antidiabetics
- Simple once-daily oral dosing
- Weight-neutral profile
Usage Information
Dosage
Recommended Dose: 5 mg once daily Route: Oral With or Without Food: Can be taken at any time of the day, with or without meals Note: Take at the same time every day for best results. Follow your doctor's instructions exactly.
Side Effects
Nasopharyngitis (cold-like symptoms) Cough Headache Hypoglycemia (especially when combined with insulin or sulfonylureas) Pancreatitis (rare) Hypersensitivity reactions (rash, hives, angioedema) Seek immediate medical help if signs of allergic reaction, severe abdominal pain, or signs of low blood sugar occur.
Contraindications
Type 1 diabetes mellitus Diabetic ketoacidosis Hypersensitivity to Linagliptin or any excipient History of pancreatitis (use with caution) Not recommended for use in children or adolescents under 18 years